C&D Emerging Investment
建发新兴投资
C&D Emerging Investment (建发新兴投资) is the minority-equity investment arm of Xiamen C&D Group, operating as an independent platform with a mandate across healthcare, advanced manufacturing, and TMT/consumer sectors . As of a 2025 profile, it had backed over 70 funds covering 800-plus companies, with 37 IPOs including Bloomage Biotech, MicroPort EP, and Titan Scientific . The unit styles itself as an LP with industrial background and direct-investment capability, and has been described by 暗涌Waves as "standing together with the market and industry" for its lack of domicile or capital-return requirements on GP partners . Its recent direct bets include Tashi Intelligent Navigation's $455 million pre-A round in April 2026, where it joined as a strategic industrial investor .
AI-generated — may contain errors, please verify.
Coverage
"Tashi Intelligent Navigation" Raises $455 Million in Pre-A Round, Linear Capital Continues to Back Through Three Consecutive Rounds Since Seed Stage | Linear Portfolio
China's embodied intelligence sector has set two all-time fundraising records simultaneously.
线性资本·Where Are the Bold State Investors?
Breaking Down the Most Active Local State-Owned Capital.
暗涌Waves·Linear Capital and C&D Group co-hosted a digital transformation salon, exploring how innovative technology products can be deployed in real-world business scenarios.
At the end of March, Linear Capital brought several of its portfolio companies to meet with C&D Group, co-hosting a digitalization salon at the Shanghai C&D Tower alongside C&D Emerging Investment and C&D Group's informatization center. Over the course of an afternoon, Linear Capital and its portfolio companies engaged with C&D Group's headquarters and informatization teams across various industry groups to discuss current technology trends and explore how these cutting-edge products and solutions could be applied across Xiamen C&D's diverse business areas.
线性资本·
